ID: ALA4794692

Max Phase: Preclinical

Molecular Formula: C34H39ClF3N7O7

Molecular Weight: 636.15

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N/C(=N/C(=O)NCCNC(=O)CCl)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C32H38ClN7O5.C2HF3O2/c33-20-27(42)35-18-19-37-32(45)40-31(34)36-17-7-12-26(29(43)38-21-22-13-15-25(41)16-14-22)39-30(44)28(23-8-3-1-4-9-23)24-10-5-2-6-11-24;3-2(4,5)1(6)7/h1-6,8-11,13-16,26,28,41H,7,12,17-21H2,(H,35,42)(H,38,43)(H,39,44)(H4,34,36,37,40,45);(H,6,7)/t26-;/m1./s1

Standard InChI Key:  FRTFRUYQUIDBPR-UFTMZEDQSA-N

Associated Targets(Human)

Neuropeptide Y receptor type 1 5019 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 636.15Molecular Weight (Monoisotopic): 635.2623AlogP: 2.07#Rotatable Bonds: 15
Polar Surface Area: 187.04Molecular Species: BASEHBA: 5HBD: 7
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.49CX Basic pKa: 9.03CX LogP: 1.35CX LogD: 0.22
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.06Np Likeness Score: -0.40

References

1. Buschmann, Jonas, Seiler, Theresa, Bernhardt, Gunther, Keller, Max, Wifling, David.  (2020)  Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of Nomega-carbamoyl substituents determines Y1R binding mode and affinity,  11  (2): [PMID:33479634] [10.1039/c9md00538b]

Source